WCN26-6889 ROLE OF NOVEL BIOMARKERS URINARY NGAL AND MCP-1 IN PREDICTING PROGRESSION OF DIABETIC KIDNEY DISEASE IN TYPE2 DM

Read full text Summarise with VIRAT
Authors: Shilna Muttickal Swaminathan, Shankar Prasad Nagaraju, Mohan Varadanayakanahalli Bhojaraja, Indu Ramachandra Rao, R.A.V.I.N.D.R.A. PRABHU ATTUR, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Shivashankara Kaniyoor Nagri, Sahana Shetty, Ravindra Maradi, Ankur Gupta, Kirthinath Ballala
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The prediction of rapid progression in patients with diabetic kidney disease (DKD) remains a global challenge. This study aimed to evaluate the prognostic utility of two non-invasive biomarkers—neutrophil gelatinase-associated lipocalin (NGAL) and monocyte chemoattractant protein-1 (MCP-1)—for identifying rapid DKD progression.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Acute Kidney Injury Research Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104639–104639
Publication date
25 March 2026
Language
EN